Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Filings indexed 442 across all filing types
Latest filing 2025-02-27 Call Transcript
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on February 24, 2025, discussing the financial results for the quarter ended December 31, 2024. It includes management commentary on financial performance, operational updates, and a Q&A session with analysts and investors. The content is a full text transcript of the call, not just an announcement or summary. Therefore, it fits the definition of a Call Transcript (CT).
2025-02-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the availability of an audio recording of an earnings conference call for the quarter ended December 31, 2024. It references the earnings call but does not contain the transcript or financial data itself. The document length is only 1252 characters, which is quite short and fits the pattern of an announcement rather than the full transcript. According to the rules, announcements about availability of conference call recordings or transcripts should be classified as Regulatory Filings (RNS) because they do not contain the full transcript or substantive financial data. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-02-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is an invitation and intimation for an earnings call scheduled on February 24, 2025, to discuss the unaudited financial results for the quarter ended December 31, 2024. It includes details about the call, participants, and dial-in information but does not contain any financial data or results itself. This matches the definition of a Call Transcript (CT) document type, which is the full text transcript of company conference calls. However, since this document is only an invitation and not the transcript itself, it is not a CT. It is also not an Earnings Release (ER) because it does not announce financial results, only the call to discuss them. The document is not a Regulatory Filing (RNS) because it is a specific announcement about the earnings call. Given the options, the best fit is Call Transcript (CT) category as it relates directly to the earnings call event, even though it is an invitation rather than a transcript, it is the closest specific category available. Confidence is high due to clear mention of earnings call and related details.
2025-02-20 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is dated February 15, 2025, and is addressed to stock exchanges in India, referencing the publication of financial results for the quarter ended December 31, 2024. It mentions the outcome of a board meeting held on February 14, 2025, where the quarterly financial results were considered and approved. The document includes extracts of the newspaper publication of these financial results and requests the information be taken on record. The content is focused on announcing the publication of quarterly financial results rather than providing the full detailed financial report itself. The document length is about 15,000 characters, but the main body is an announcement of the publication of the financial results in newspapers, not the full interim or quarterly report. Therefore, according to the "Menu vs Meal" rule, this is an announcement of the report, not the report itself. Hence, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about the publication of quarterly financial results.
2025-02-15 English
Integrated Filing- Financial
Regulatory Filings
2025-02-14 English
General Updates
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the designation of various individuals as Senior Management Personnel of the company, effective February 14, 2025. It references compliance with SEBI Listing Regulations and includes detailed profiles and appointment reasons for each individual. There are no financial statements, earnings data, or audit information. The content focuses on management personnel changes and their profiles, which aligns with announcements about changes in senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is substantial (15,000 characters), indicating it is not a brief announcement or a report publication notice but a detailed management change disclosure.
2025-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.